Cantor Equity Partners V, Inc. Annual Report - How They Did This Year

This guide explains how Cantor Equity Partners V, Inc. (CEPV) performed over the past year. My goal is to break down the filing information into simple terms so you can decide if this company fits your investment goals.

1. What does this company do?

Cantor Equity Partners V is a "Special Purpose Acquisition Company," or SPAC. Think of it as a "blank check" company. It has no products, factories, or services. It was formed to raise money to find and buy an existing private company and take it public. They hit the Nasdaq on November 5, 2025, under the ticker CEPV. They raised $250 million by selling 25 million units at $10.00 each. Each unit included one share of stock and half of a warrant.

2. The "Hunt" Strategy

The team is looking for companies in financial services, digital assets, healthcare, real estate, or tech. They have until November 5, 2027, to find a deal. If they fail, they must return the $250 million (plus interest) to shareholders. The process involves finding a target, agreeing on a merger, and getting shareholder approval.

3. Financial Health and the "Deal"

As of December 31, 2025, $250 million sits in a trust account. This money is invested in short-term U.S. Treasury securities.

• The 80% Rule: They must buy a business worth at least 80% of the money in the trust.
• Need for extra cash: If the target company costs more than $250 million, they may issue more shares or take on debt. This could lead to more shares being issued, which reduces your ownership percentage in the company.
• Profitability: The company reported a profit of $1.23 million for 2025. This came entirely from interest on the Treasury securities, minus operating costs.
• Redemption Value: At the end of 2025, your share of the trust was worth about $10.06. This is your $10.00 investment plus interest. This acts as a floor for your investment if you choose to cash out during a merger vote.

4. Who is running the show?

The leadership team is experienced but manages several other "Cantor" SPACs. While they are experts, they are splitting their focus across multiple "hunts," which may limit the time they spend finding a target for CEPV.

5. Key Risks

• "Controlled Company" Status: The founders hold all "Class B" shares, representing 20% of the company. This gives them total control over board elections and merger approvals. Retail investors have no voting power on these decisions.
• Conflicts of Interest: The team runs multiple SPACs and might find a target that fits both CEPV and another Cantor SPAC. They have no duty to prioritize your company.
• Hidden Costs: While there is a $10,000 monthly fee for office space, there is no limit on how much the founders can be reimbursed for "out-of-pocket" expenses. These costs come out of the company’s cash.
• "Single Shot" Risk: Your investment depends entirely on the one business they eventually buy. If that company fails, you have no other assets to protect your money.
• Reporting Limits: As an "emerging growth company," they provide less financial transparency than a typical public company.

Is this right for you? Investing in a SPAC like CEPV is a bet on the management team's ability to find a high-quality company before their 2027 deadline. Because you don't know what you are buying yet, consider whether you are comfortable with the "controlled company" structure and the potential for the founders to prioritize other projects over this one. If you prefer transparency and immediate business operations, this may not be the right fit for your portfolio.